Tick-borne encephalitis (TBE) virus is the causative agent of tick-borne encephalitis (TBE), a potentially fatal neurological infection. The virus is transmitted to humans through the bite of infected Ixodes tick species which are endemic to a large area stretching from Southern Germany, across Russia to the islands of Northern Japan. Inactivated whole virus vaccines are licensed in Europe to prevent TBE and given to populations at risk in various countries. Novartis Vaccines, Baxter vaccines and Russian local companies are the major manufacturers of TBE vaccines.
This MarketVIEW product is a comprehensive MS Excel-based model + summary presentation which forecasts the potential commercial value of TBE vaccines across endemic markets to 2030. The model contains value ($ m) and volume (mio doses) predictions for each country and discusses current dynamics in disease incidence and possible market upside scenarios. THIS PRODUCT IS A SUMMARY PRESENTATION + MODEL